Diabetes mellitus, oxidative stress and endothelial dysfunction

International Congress Series

Volumn 1253, Issue C, 2003, Pages 125-138

  Sydow, Karsten ^a   Münzel, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Asymmetric dimethylarginine; Diabetes mellitus; Nitric oxide; Oxidative stress; Protein kinase C

Indexed keywords

EID: 67650814719     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(02)01280-3     Document Type: Article

References (64)

1. Ishii, H., Koya, D., King, G.L., Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J. Mol. Med. 76:1 (1998), 21–31.
2. Suwaidi, J.A., Hamasaki, S., Higano, S.T., Nishimura, R.A., Holmes, D.R. Jr., Lerman, A., Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:9 (2000), 948–954.
3. Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., Munzel, T., Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:22 (2001), 2673–2678.
4. Schachinger, V., Britten, M.B., Zeiher, A.M., Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:16 (2000), 1899–1906.
5. Halcox, J.P., Schenke, W.H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M.A., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106:6 (2002), 653–658.
6. Ting, H.H., Timimi, F.K., Boles, K.S., Creager, S.J., Ganz, P., Creager, M.A., Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 97 (1996), 22–28.
7. Tesfamariam, B., Brown, M.L., Cohen, R.A., Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J. Clin. Invest. 87:5 (1991), 1643–1648.
8. Pieper, G.M., Moore-Hilton, G., Roza, A.M., Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci. 58:9 (1996), PL147–PL152.
9. Timimi, F.K., Ting, H.H., Haley, E.A., Roddy, M.A., Ganz, P., Creager, M.A., Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 31:3 (1998), 552–557.
10. Beckman, J.A., Goldfine, A.B., Gordon, M.B., Creager, M.A., Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103:12 (2001), 1618–1623.
11. Williams, S.B., Cusco, J.A., Roddy, M.A., Johnstone, M.T., Creager, M.A., Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 27:3 (1996), 567–574.
12. Lund, D.D., Faraci, F.M., Miller, F.J. Jr., Heistad, D.D., Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 101:9 (2000), 1027–1033.
13. Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88:2 (2001), E14–E22.
14. Cosentino, F., Hishikawa, K., Katusic, Z.S., Luscher, T.F., High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:1 (1997), 25–28.
15. Vasquez-Vivar, J., Kalyanaraman, B., Martasek, P., Hogg, N., Masters, B.S.S., Karoui, H., et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U. S. A. 95:16 (1998), 9220–9225.
16. Xia, Y., Tsai, A.L., Berka, V., Zweier, J.L., Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J. Biol. Chem. 273:40 (1998), 25804–25808.
17. Kossenjans, W., Eis, A., Sahay, R., Brockman, D., Myatt, L., Role of peroxynitrite in altered fetal–placental vascular reactivity in diabetes or preeclampsia. Am. J. Physiol., Heart Circ. Physiol. 278:4 (2000), H1311–H1319.
18. Milstien, S., Katusic, Z., Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem. Biophys. Res. Commun. 263:3 (1999), 681–684.
19. Laursen, J.B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B.A., et al. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103:9 (2001), 1282–1288.
20. Zou, M.H., Shi, C., Cohen, R.A., Oxidation of the zinc–thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109:6 (2002), 817–826.
21. Boger, R.H., Sydow, K., Borlak, J., Thum, T., Lenzen, H., Schubert, B., et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ. Res. 87:2 (2000), 99–105.
22. Masuda, H., Goto, M., Tamaoki, S., Azuma, H., Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. Br. J. Pharmacol. 126:1 (1999), 211–218.
23. Cooke, J.P., Does ADMA cause endothelial dysfunction?. Arterioscler. Thromb. Vasc. Biol. 20:9 (2000), 2032–2037.
24. Pritchard, K.A. Jr., Groszek, L., Smalley, D.M., Sessa, W.C., Wu, M., Villalon, P., et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ. Res. 77:3 (1995), 510–518.
25. Guzik, T.J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105:14 (2002), 1656–1662.
26. Oelze, M., Mollnau, H., Hoffmann, N., Warnholtz, A., Bodenschatz, M., Smolenski, A., et al. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ. Res. 87:11 (2000), 999–1005.
27. Stroes, E., Kastelein, J., Cosentino, F., Erkelens, W., Wever, R., Koomans, H., et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Invest. 99:1 (1997), 41–46.
28. Heitzer, T., Brockhoff, C., Mayer, B., Warnholtz, A., Mollnau, H., Henne, S., et al. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ. Res. 86:2 (2000), E36–E41.
29. Heitzer, T., Krohn, K., Albers, S., Meinertz, T., Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 43:11 (2000), 1435–1438.
30. Park, J.Y., Ha, S.W., King, G.L., The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit. Dial. Int. 19:Suppl. 2 (1999), S222–S227.
31. Inoguchi, T., Battan, R., Handler, E., Sportsman, J.R., Heath, W., King, G.L., Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. U. S. A. 89:22 (1992), 11059–11063.
32. Ishii, H., Jirousek, M.R., Koya, D., Takagi, C., Xia, P., Clermont, A., et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272:5262 (1996), 728–731.
33. Tesfamariam, B., Cohen, R.A., Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 263:2 Pt. 2 (1992), 321–326.
34. Hirata, K., Kuroda, R., Sakoda, T., Katayama, M., Inoue, N., Suematsu, M., et al. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25:2 (1995), 180–185.
35. Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 89:1 (2001), 888–894.
36. Inoguchi, T., Li, P., Umeda, F., Yu, H.Y., Kakimoto, M., Imamura, M., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:11 (2000), 1939–1945.
37. Griendling, K.K., Sorescu, D., Ushio-Fukai, M., NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86:5 (2000), 494–501.
38. Jones, S.A., O'Donnell, V.B., Wood, J.D., Broughton, J.P., Hughes, E.J., Jones, O.T., Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271:4 Pt. 2 (1996), H1626–H1634.
39. Wang, H.D., Pagano, P.J., Du, Y., Cayatte, A.J., Quinn, M.T., Brecher, P., et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ. Res. 82:7 (1998), 810–818.
40. Bastian, N.R., Hibbs, J.B. Jr., Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr. Opin. Immunol. 6:1 (1994), 131–139.
41. Gorlach, A., Brandes, R.P., Nguyen, K., Amidi, M., Dehghani, F., Busse, R., A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87:1 (2000), 26–32.
42. Dekker, L.V., Leitges, M., Altschuler, G., Mistry, N., McDermott, A., Roes, J., et al. Protein kinase C-beta contributes to NADPH oxidase activation in neutrophils. Biochem. J. 347 Pt. 1 (2000), 285–289.
43. Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura, T., Kaneda, Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:6779 (2000), 787–790.
44. Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 414:6865 (2001), 813–820.
45. Li, H., Oehrlein, S.A., Wallerath, T., Ihrig-Biedert, I., Wohlfart, P., Ulshofer, T., et al. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene. Mol. Pharmacol. 53:4 (1998), 630–637.
46. Drummond, G.R., Cai, H., Davis, M.E., Ramasamy, S., Harrison, D.G., Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ. Res. 86:3 (2000), 347–354.
47. Mulsch, A., Bauersachs, J., Schafer, A., Stasch, J.P., Kast, R., Busse, R., Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br. J. Pharmacol. 120:4 (1997), 681–689.
48. Ruetten, H., Zabel, U., Linz, W., Schmidt, H.H., Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ. Res. 85:6 (1999), 534–541.
49. O'Driscoll, G., Green, D., Rankin, J., Stanton, K., Taylor, R., Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J. Clin. Invest. 100:3 (1997), 678–684.
50. O'Driscoll, G., Green, D., Maiorana, A., Stanton, K., Colreavy, F., Taylor, R., Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 33:6 (1999), 1506–1511.
51. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, N. Engl. J. Med. 342 (3) (2000) 145–153.
52. Cheetham, C., Collis, J., O'Driscoll, G., Stanton, K., Taylor, R., Green, D., Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J. Am. Coll. Cardiol. 36:5 (2000), 1461–1466.
53. Cheetham, C., O'Driscoll, G., Stanton, K., Taylor, R., Green, D., Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in type II diabetes. Clin. Sci. (London) 100:1 (2001), 13–17.
54. Munzel, T., Keaney, J.F. Jr., Are ace inhibitors a “magic bullet” against oxidative stress?. Circulation 104:13 (2001), 1571–1574.
55. Tsunekawa, T., Hayashi, T., Kano, H., Sumi, D., Matsui-Hirai, H., Thakur, N.K., et al. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 104:4 (2001), 376–379.
56. Mullen, M.J., Wright, D., Donald, A.E., Thorne, S., Thomson, H., Deanfield, J.E., Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. J. Am. Coll. Cardiol. 36:2 (2000), 410–416.
57. Wagner, A.H., Kohler, T., Ruckschloss, U., Just, I., Hecker, M., Improvement of nitric oxide-dependent vasodilatation by HMG–CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler. Thromb. Vasc. Biol. 20:1 (2000), 61–69.
58. Laufs, U., La Fata, V., Plutzky, J., Liao, J.K., Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:12 (1998), 1129–1135.
59. Title, L.M., Cummings, P.M., Giddens, K., Nassar, B.A., Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J. Am. Coll. Cardiol. 36:7 (2000), 2185–2191.
60. Skyrme-Jones, R.A., O'Brien, R.C., Berry, K.L., Meredith, I.T., Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J. Am. Coll. Cardiol. 36:1 (2000), 94–102.
61. Vitamin E supplementation and cardiovascular events in high-risk patients, N. Engl. J. Med. 342 (3) (2000) 154–160.
62. Keaney, J.F. Jr., Gaziano, J.M., Xu, A., Frei, B., Curran-Celentano, J., Shwaery, G.T., et al. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J. Clin. Invest. 93:2 (1994), 844–851.
63. Palmer, A.M., Thomas, C.R., Gopaul, N., Dhir, S., Anggard, E.E., Poston, L., et al. Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia 41:2 (1998), 148–156.
64. Beckman, J.A., Goldfine, A.B., Gordon, M.B., Garrett, L.A., Creager, M.A., Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ. Res. 90:1 (2002), 107–111.